enVVeno Medical annual current ratio
2018
2019
2020
2021
2022
2023
2024
2025
enVVeno Medical Current Ratio Growth & History (NVNO)
enVVeno Medical's current ratio was 13.58 for fiscal 2025.
View full enVVeno Medical company overviewenVVeno Medical annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 13.58 | −7.29 | −34.93% |
| 2024 | 2024-12-31 | 20.88 | −13.35 | −39.01% |
| 2023 | 2023-12-31 | 34.23 | 8.45 | +32.78% |
| 2022 | 2022-12-31 | 25.78 | −9.06 | −26.01% |
| 2021 | 2021-12-31 | 34.84 | 31.83 | +1059.93% |
| 2020 | 2020-12-31 | 3.00 | 2.24 | +295.75% |
| 2019 | 2019-12-31 | 0.76 | −1.10 | −59.26% |
| 2018 | 2018-12-31 | 1.86 | — | — |
enVVeno Medical quarterly current ratio
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 11.70 | −0.11 | −0.90% |
| Q1 2026 | 2026-03-31 | 11.89 | −11.87 | −49.96% |
| Q4 2025 | 2025-12-31 | 13.58 | −7.29 | −34.93% |
| Q3 2025 | 2025-09-30 | 13.12 | −8.88 | −40.36% |
| Q2 2025 | 2025-06-30 | 11.81 | −11.52 | −49.37% |
| Q1 2025 | 2025-03-31 | 23.77 | −5.32 | −18.28% |
| Q4 2024 | 2024-12-31 | 20.88 | −13.35 | −39.01% |
| Q3 2024 | 2024-09-30 | 22.01 | 9.10 | +70.48% |
| Q2 2024 | 2024-06-30 | 23.33 | 8.76 | +60.13% |
| Q1 2024 | 2024-03-31 | 29.08 | −0.50 | −1.67% |
| Q4 2023 | 2023-12-31 | 34.23 | 8.45 | +32.78% |
| Q3 2023 | 2023-09-30 | 12.91 | −18.31 | −58.65% |
| Q2 2023 | 2023-06-30 | 14.57 | −6.23 | −29.95% |
| Q1 2023 | 2023-03-31 | 29.58 | −11.09 | −27.27% |
| Q4 2022 | 2022-12-31 | 25.78 | −9.06 | −26.01% |
| Q3 2022 | 2022-09-30 | 31.22 | −20.84 | −40.03% |
| Q2 2022 | 2022-06-30 | 20.79 | −8.95 | −30.09% |
| Q1 2022 | 2022-03-31 | 40.67 | 17.10 | +72.56% |
| Q4 2021 | 2021-12-31 | 34.84 | 31.83 | +1059.93% |
| Q3 2021 | 2021-09-30 | 52.06 | 48.94 | +1568.08% |
| Q2 2021 | 2021-06-30 | 29.74 | 29.14 | +4821.11% |
| Q1 2021 | 2021-03-31 | 23.57 | 23.20 | +6219.85% |
| Q4 2020 | 2020-12-31 | 3.00 | 2.24 | +295.75% |
| Q3 2020 | 2020-09-30 | 3.12 | 1.60 | +105.55% |
| Q2 2020 | 2020-06-30 | 0.60 | −1.85 | −75.42% |
| Q1 2020 | 2020-03-31 | 0.37 | −1.23 | −76.72% |
| Q4 2019 | 2019-12-31 | 0.76 | −1.10 | −59.26% |
| Q3 2019 | 2019-09-30 | 1.52 | — | — |
| Q2 2019 | 2019-06-30 | 2.46 | — | — |
| Q1 2019 | 2019-03-31 | 1.60 | — | — |
| Q4 2018 | 2018-12-31 | 1.86 | — | — |
enVVeno Medical current ratio trends
Over the last five fiscal years, enVVeno Medical's current ratio increased from 3.00 to 13.58, a change of 10.58. The latest reported quarter, Q2 2026, shows 11.70.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review enVVeno Medical source filings ↗